Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content


Pfizer is voluntarily recalling two lots of Chantix 0.5mg Tablets, two lots of Chantix 1 mg Tablets, and eight lots of a Chantix kit of 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily I (US Food Recalls) More More

Similar stories

JPMorgan restricts employee use of ChatGPT | News | kadn.com - KADN

JPMorgan restricts employee use of ChatGPT | News | kadn.com  KADN

Posted on 22 February 2023 | 3:00 am | Google News

No evidence suggests that Pfizer’s smoking cessation medication Chantix increases the risk of cancer; recall of this ... - Health Feedback

No evidence suggests that Pfizer’s smoking cessation medication Chantix increases the risk of cancer; recall of this ...  Health Feedback

Posted on 5 November 2021 | 2:00 am | Google News

Chantix Recalled over Potential Cancer Risk - DrugWatch.com

Chantix Recalled over Potential Cancer Risk  DrugWatch.com

Posted on 23 September 2021 | 2:00 am | Google News

Pfizer issues voluntary recall for FDA-approved CHANTIX citing cancer risk - Lynnwood Times

Pfizer issues voluntary recall for FDA-approved CHANTIX citing cancer risk  Lynnwood Times

Posted on 20 September 2021 | 2:00 am | Google News

Pfizer Expands Voluntary Recall to Include All Lots of CHANTIX® Tablets Due to N-Nitroso Varenicline Content - RLS Media

Pfizer Expands Voluntary Recall to Include All Lots of CHANTIX® Tablets Due to N-Nitroso Varenicline Content  RLS Media

Posted on 17 September 2021 | 2:00 am | Google News

Pfizer recall anti-smoking drug Chantix for high levels nitrosamine, which can increase cancer risk - Daily Mail

Pfizer recall anti-smoking drug Chantix for high levels nitrosamine, which can increase cancer risk  Daily Mail

Posted on 17 September 2021 | 2:00 am | Google News

Copyright © 2024 LastMinuteStuff.com | Contact info